ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising enhancements throughout many healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, additional reliable alternative for therapeutic use, sig